UBTFL1 inhibitors represent a class of chemical compounds designed to interact with the UBTFL1 protein, an entity involved in various intracellular processes, particularly those related to cellular regulation and protein modification. UBTFL1 is part of a larger family of ubiquitin-like proteins that are essential in modulating protein-protein interactions, signal transduction, and degradation pathways within cells. By influencing the function of UBTFL1, these inhibitors potentially modulate the ubiquitination process, which is pivotal for maintaining protein homeostasis and controlling various cellular events such as cell cycle progression, stress response, and DNA repair. UBTFL1 inhibitors are characterized by their ability to selectively bind to the active sites or regulatory domains of the UBTFL1 protein, thereby altering its function and preventing its interaction with other key cellular substrates.
The design of UBTFL1 inhibitors typically relies on detailed structural analyses of the UBTFL1 protein, where molecular modeling and crystallography play significant roles. These inhibitors are crafted to exhibit high specificity and affinity for UBTFL1, minimizing off-target interactions and allowing for the precise modulation of cellular pathways associated with this protein. Through the inhibition of UBTFL1, researchers can study how the protein influences intricate biological mechanisms like autophagy, protein folding, and cellular response to stress. As with many proteins involved in the ubiquitin pathway, UBTFL1 plays a role in balancing cellular homeostasis, making its inhibitors valuable tools for probing deeper into how cells manage protein degradation and recycling, as well as how they maintain the integrity of various signaling networks.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
Inhibits DNA methyltransferases, potentially affecting gene expression patterns related to UBTFL1 functions in cell proliferation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Histone deacetylase inhibitor, potentially influencing chromatin remodeling and gene expression related to UBTFL1 activity. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $321.00 | ||
CDK4/6 inhibitor, potentially affecting cell cycle regulation and thus indirectly influencing UBTFL1-related cell proliferation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor, potentially influencing pathways related to cell growth and proliferation, which could intersect with UBTFL1 activity. | ||||||
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $62.00 $225.00 $779.00 | 24 | |
MDM2 antagonist, potentially stabilizing p53 and affecting cell cycle regulation related to UBTFL1 functions. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
ROCK inhibitor, potentially affecting cell migration and adhesion processes relevant to embryonic cell development where UBTFL1 is involved. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, possibly influencing signaling pathways that overlap with UBTFL1's function in cell proliferation. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
Inhibits ALK5, impacting TGF-β signaling which might intersect with UBTFL1's role in cell proliferation and development. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor, which might indirectly affect UBTFL1 activity by altering cell proliferation and survival signaling pathways. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Proteasome inhibitor, potentially influencing protein degradation pathways that could indirectly affect UBTFL1 functions. | ||||||